Expertise in
11
conditions

Tim E. Hassall

South Brisbane, QLD, AU 
Clinical Trials:Currently Recruiting for 1 Trial
Expertise in
11
conditions
South Brisbane, QLD, AU 

Overview

Tim Hassall practices practicing medicine in South Brisbane, Australia.

Mr. Hassall is highly rated in 11 conditions, according to our data. His clinical expertise encompasses Pineoblastoma, Diffuse Midline Glioma H3 K27M-Mutant, Brain Stem Cancer, and Posterior Fossa Tumor.

He is actively involved in clinical research, co-authoring 32 peer reviewed articles and participating in 5 clinical trials.

Gender

Male

Locations

South Brisbane, QLD, Australia
Other Locations
Brisbane, QLD, Australia
Parkville, VIC, Australia

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

A Phase 1/2, Open-Label, Safety, Tolerability, Pharmacokinetics, and Anti-Tumor Activity Study of Repotrectinib in Pediatric and Young Adult Subjects With Advanced or Metastatic Malignancies Harboring ALK, ROS1, NTRK1-3 Alterations
A Phase 1/2, Open-Label, Safety, Tolerability, Pharmacokinetics, and Anti-Tumor Activity Study of Repotrectinib in Pediatric and Young Adult Subjects With Advanced or Metastatic Malignancies Harboring ALK, ROS1, NTRK1-3 Alterations
Enrollment Status: Recruiting
Publish Date: November 19, 2025
Intervention Type: Drug
Study Drug: Oral Repotrectinib (TPX-0005)
Study Phase: Phase 1/Phase 2
A Single Arm, Pilot of Neoadjuvant Checkpoint Inhibition Followed by Adjuvant Checkpoint Inhibition in Children and Young Adults With Recurrent or Progressive High Grade Glioma (HGG)
A Single Arm, Pilot of Neoadjuvant Checkpoint Inhibition Followed by Adjuvant Checkpoint Inhibition in Children and Young Adults With Recurrent or Progressive High Grade Glioma (HGG)
Enrollment Status: Active_not_recruiting
Publish Date: June 15, 2026
Intervention Type: Biological, Other
Study Drugs: Ipilimumab, Nivolumab
Study Phase: Phase 1
A Clinical and Molecular Risk-Directed Therapy for Newly Diagnosed Medulloblastoma
A Clinical and Molecular Risk-Directed Therapy for Newly Diagnosed Medulloblastoma
Enrollment Status: Active_not_recruiting
Publish Date: November 13, 2025
Intervention Type: Drug, Other, Radiation
Study Drugs: Cyclophosphamide, Cisplatin, Vincristine, Vismodegib, Pemetrexed, Gemcitabine
Study Phase: Phase 2
A Phase 1 Study of the EZH2 Inhibitor Tazemetostat in Pediatric Subjects With Relapsed or Refractory INI1-Negative Tumors or Synovial Sarcoma
A Phase 1 Study of the EZH2 Inhibitor Tazemetostat in Pediatric Subjects With Relapsed or Refractory INI1-Negative Tumors or Synovial Sarcoma
Enrollment Status: Completed
Publish Date: October 03, 2024
Intervention Type: Drug
Study Drug: Tazemetostat
Study Phase: Phase 1
View 3 Less Clinical Trials

32 Total Publications

Financial Burden Associated With Hospitalisation Among Families of Childhood Brain Tumours in Australia.
Financial Burden Associated With Hospitalisation Among Families of Childhood Brain Tumours in Australia.
Journal: Pediatric blood & cancer
Published: December 18, 2025

Frequently Asked Questions about Tim E. Hassall

Is Tim E. Hassall a top-rated expert for Pineoblastoma?

MediFind is an objective health platform that identifies experts based on real-world data. Tim E. Hassall is classified as an Advanced expert for Pineoblastoma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Tim E. Hassall participate in research or clinical trials?

Yes. Tim E. Hassall has published 32 articles and abstracts on conditions like Pineoblastoma. You can view a list of Tim E. Hassall's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Hassall's expertise for a condition
ConditionClose
      View All 11 Advanced Conditions
      View All 9 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile